CGP-based IO biomarker assessment and treatment utilization across a major US health system.
Alexa K. Dowdell(Providence Portland Medical Center), Brian Piening(Providence College), Ryan Meng(Providence Portland Medical Center), Bela Bapat(Illumina (United States)), Maude Champagne(Illumina (United States)), Cliff Wong(Microsoft (United States)), Brock E. Schroeder(Illumina (United States)), Carlo Bifulco(Providence Health & Services), Douglas Hanes(Providence Portland Medical Center), Ann Vita(Providence Health & Services), Roshanthi Weerasinghe(Providence College), John Leonard Fox(Illumina (United States)), Hoifung Poon(Microsoft (United States))
Cited by 0
Related Papers
The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight
|Science|2019|1.1k
Cancer classification using the Immunoscore: a worldwide task force
|Journal of Translational Medicine|2012|803
Longitudinal multi-omics of host–microbe dynamics in prediabetes
|Nature|2019|620